Male Cancer - Pipeline Review, H2 2012 New Report
Male Cancer - Pipeline Review, H2 2012, provides an overview of the Male Cancer therapeutic pipeline. This report provides information on the therapeutic development for Male Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Cancer. 'Male Cancer - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured...
View full press release